Prostatectomy News and Research

RSS
Majority of men on ADT after prostatectomy gain weight during first year of therapy

Majority of men on ADT after prostatectomy gain weight during first year of therapy

Surgical robot acquisition increases rate of surgery to treat prostate cancer

Surgical robot acquisition increases rate of surgery to treat prostate cancer

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

Eigen ei-Nav|Artemis system for prostate biopsy installed at Smilow Comprehensive Prostate Cancer Center

HealthGrades recognizes America's 50 Best Hospitals for 2011

HealthGrades recognizes America's 50 Best Hospitals for 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Sequencing of whole prostate cancer genomes - an historic development

Sequencing of whole prostate cancer genomes - an historic development

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Insufficient evidence of interstitial brachytherapy's advantages for localized prostate cancer treatment

Insufficient evidence of interstitial brachytherapy's advantages for localized prostate cancer treatment

Negative aspects of prostate cancer screening acceptable

Negative aspects of prostate cancer screening acceptable

World's largest medical robotic conference

World's largest medical robotic conference

High-dose rate brachytherapy procedure to treat prostate cancer

High-dose rate brachytherapy procedure to treat prostate cancer

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Expert discusses androgen deprivation therapy for prostate cancer

Expert discusses androgen deprivation therapy for prostate cancer

VIVUS reports positive results from avanafil phase 3 study in erectile dysfunction

VIVUS reports positive results from avanafil phase 3 study in erectile dysfunction

Active surveillance improves quality of life in low-risk prostate cancer patients

Active surveillance improves quality of life in low-risk prostate cancer patients

Study finds no link between prostate cancer clinical stage and risk of recurrence after radical prostatectomy

Study finds no link between prostate cancer clinical stage and risk of recurrence after radical prostatectomy

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

Multidisciplinary clinic approach can improve survival in patients with aggressive prostate cancer

Long-term androgen deprivation therapy increases risk of fracture in older men with prostate cancer

Long-term androgen deprivation therapy increases risk of fracture in older men with prostate cancer

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA Pharma announces 10-year outcome data of PROSTASCINT in prostate cancer radiotherapy

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.